Xiaolan Bian
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 3
-
- Glaucoma and retinal disorders 2
- Co-authors
- Liang Zhang (2 shared papers)Zhitao Yang (3 shared papers)Hai‐Shu Lin (1 shared paper)Guochao Shi (1 shared paper)Yiqun Yu (1 shared paper)Size Li (1 shared paper)Yan‐Ru Lou (1 shared paper)Min Li (1 shared paper)
- Journals
- Annals of Translational Medicine (3 papers)Frontiers in Pharmacology (3 papers)Talanta (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Infectious Diseases and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaolan Bian
36 papers receiving 413 citations
Peers
Comparison fields: 5 of 53
- Molecular Medicine 89
- Drug Discovery 1
- Pharmacology 45
- Ophthalmology 25
- Pharmacology 14
Countries citing papers authored by Xiaolan Bian
This map shows the geographic impact of Xiaolan Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Bian more than expected).
Fields of papers citing papers by Xiaolan Bian
This network shows the impact of papers produced by Xiaolan Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Bian. The network helps show where Xiaolan Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2021 | 39 | |
| 3 | 2021 | 34 | |
| 4 | 2022 | 29 | |
| 5 | 2020 | 25 | |
| 6 | 2021 | 24 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 13 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2022 | 8 |
About Xiaolan Bian
Xiaolan Bian is a scholar working on Molecular Medicine, Ophthalmology, Pharmacology, Nephrology and Pathology and Forensic Medicine, having authored 38 papers that have together received 420 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), Acute Kidney Injury Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Glaucoma and retinal disorders (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Magnolia and Illicium research (1 paper). The work is most often cited by research in Molecular Medicine (89 citations), Drug Discovery (1 citation), Pharmacology (45 citations), Ophthalmology (25 citations) and Pharmacology (14 citations). Xiaolan Bian has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Liang Zhang, Zhitao Yang, Hai‐Shu Lin, Guochao Shi, Yiqun Yu, Size Li, Yan‐Ru Lou, Min Li, Min Zhang and Yujie Wang. Their work appears in journals such as Annals of Translational Medicine, Frontiers in Pharmacology, Talanta, Journal of Pharmaceutical and Biomedical Analysis and Infectious Diseases and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.